The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
Biosimilar Pipeline Analysis Market BURLINGAME, CA, UNITED STATES, February 6, 2025 /EINPresswire / -- The global Biosimilar Pip ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
4Q Earnings: $410 million (loss of $3.4 billion 4Q24) ...
14d
Pharmaceutical Technology on MSNPfizer settles Biohaven kickback claims case for $59.7mBiohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results